BackVincerx Pharma Overview

Vincerx Pharma Current Assets

Latest current assets for VINC: $4.7M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$4.69M
38.96% YoYΔ $-2.99M vs prior year quarter

Peer average

Loading

Vincerx Pharma Current Assets History

Loading

Vincerx Pharma vs. peers: Current Assets Comparison

Loading

Vincerx Pharma Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Vincerx Pharma (VINC) FAQ

Vincerx Pharma's current assets stands at $4.7M as of March 2025. That compares with $7.7M in the prior-year period — down 39.0% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Vincerx Pharma reported $4.7M in current assets versus $7.7M a year earlier — a 39.0% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $7.7M in the prior-year period — down 39.0% year over year. Sustained growth in current assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Vincerx Pharma's current assets evolved across reporting periods, while the comparison chart places VINC next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, current assets is commonly used to spot outliers. Vincerx Pharma's reading of $4.7M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.